You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cardiac amyloidosis: An update on diagnosis and treatment
|
|---|---|
| Published in |
Cleveland Clinic Journal of Medicine, January 2017
|
| DOI | 10.3949/ccjm.84.s3.02 |
| Pubmed ID | |
| Authors |
Joseph P Donnelly, Mazen Hanna |
| Abstract |
Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due to enhanced clinical awareness and better diagnostic imaging. CA is becoming of heightened interest to the cardiology community given more effective treatment strategies for light chain amyloidosis (AL), as well as emerging therapies for transthyretin amyloidosis (ATTR). Furthermore, reversing amyloid deposition in affected organs using monoclonal antibodies is actively being tested in clinical trials. A high index of suspicion and a systematic approach to the diagnosis of CA can lead to referral to a center of expertise for timely treatment. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 203 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 203 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 14% |
| Other | 23 | 11% |
| Student > Bachelor | 23 | 11% |
| Student > Master | 16 | 8% |
| Student > Postgraduate | 13 | 6% |
| Other | 32 | 16% |
| Unknown | 67 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 43% |
| Biochemistry, Genetics and Molecular Biology | 18 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Agricultural and Biological Sciences | 4 | 2% |
| Social Sciences | 4 | 2% |
| Other | 13 | 6% |
| Unknown | 70 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2017.
All research outputs
#18,579,736
of 23,012,811 outputs
Outputs from Cleveland Clinic Journal of Medicine
#1,059
of 1,264 outputs
Outputs of similar age
#311,467
of 421,297 outputs
Outputs of similar age from Cleveland Clinic Journal of Medicine
#30
of 41 outputs
Altmetric has tracked 23,012,811 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,264 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,297 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.